Series A funding round for Gilgamesh Pharmaceuticals raising $27M in May 2021
Series A funding round for Gilgamesh Pharmaceuticals raising $27M in May 2021
| Investor | Firm Type | Partner |
|---|
Prime Movers LabLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Syndicate | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$88.2M
Top Valuation
-
Gilgamesh Pharmaceuticals raised $27M in a Series A round.
The round was announced on 05/01/21.
The round was led by Prime Movers Lab.